The subject of proning to increase oxygenation of atelectatic lung areas has been studied in the PROSEVA trial mentioned earlier in the discussion. This study also recommends the use of early NM blockade in severe ARDS patients. The recent ROSE trial stated there no mortality benefit and even potential cardiovascular harm to those receiving early NM blockade. Did you notice any difference in use between the two arms? I'm wondering if early NM blockade may show benefit in some select scenarios.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.